Company

CND Life Sciences

Rocket Ship Rating

Rocket Ship Rating: 94 out of 100

The first commercially available skin-based test to help clinicians diagnose Parkinson’s disease and related disorders.

Also known as CND LIFE SCIENCES, INC.

Medical devices & diagnostics

Status: Operatingas of 2026-09-17
Business model: B2B
Headquarters: Scottsdale, Arizona, United States
Founded: 2017
Customers: clinicians
Legal name: CND LIFE SCIENCES, INC.

Open relationship map

Claim, correct or request removal

Record updated 28 September 2026

About

CND is driven by a mission to advance care for patients facing the possibility of a neurodegenerative disease.

Funding snapshot

Total raised: $28MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
Latest round: Round, $4.3M2026-06-09

Funding rounds

Round, 2026: $4.3M2026-06-09, SEC form D sold, 1 investor
Round, 2026: $6.3M2026-06-09, SEC form D sold, 14 investors
Round, 2025: $8.6M2025-02-28, SEC form D sold, 38 investors
Round, 2024: $2M2024-03-20, SEC form D sold, 22 investors
Round, 2023: $1.5M2023-07-14, SEC form D sold, 19 investors
Round, 2022: $4.5M2022-09-16, SEC form D sold, 26 investors
Round, 2021: $4.2M2021-10-29, SEC form D sold, 22 investors
Round, 2021: $2.9M2021-01-05, SEC form D sold, 20 investors

Products

Other: Syn-One Test